Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Nov 9;16:307. doi: 10.1186/s12967-018-1679-0

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 2 — Post-recurrence survival (PRS) for each intrinsic subtype and for pathological response. Although TNBC was associated with the worst prognosis, PRS was not significantly different in each subtype (p = 0.396, log-rank) (a). Patients who achieved pCR had significantly better PRS among all breast cancers (p = 0.021, log-rank) (b). Patients who achieved pCR had significantly better PRS of Luminal breast cancer (p = 0.031, log-rank) (c). PRS was not significantly differ between patients with pCR and non-pCR of TNBC (p = 0.329, log-rank) (d)